-
EP1629843
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1629843
| EP1629843 - Reboxetine for treating chronic fatigue syndrome [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 11.12.2009 Database last updated on 31.08.2024 | Most recent event Tooltip | 11.12.2009 | Application deemed to be withdrawn | published on 13.01.2010 [2010/02] | Applicant(s) | For all designated states Pharmacia & Upjohn Company LLC 7000 Portage Road Kalamazoo, MI 49001 / US | [2007/04] |
| Former [2006/09] | For all designated states Pharmacia & Upjohn Company LLC 301 Henrietta Street Kalamazoo, MI 49001 / US | Inventor(s) | 01 /
Wong, Erik, H., F. 7352 Hampstead Lane 49024, Portage / US | 02 /
Ahmed, Saeeduddin 9889 Defoe Court 49002, Portage / US | 03 /
Marshall, Robert, Clyde 7560 Fieldwood Circle 49071, Mattawan / US | 04 /
McArthur, Robert 531 Carrington court 49009, Kalamazoo / US | 05 /
Taylor, Duncan, P. 8722 West F Avenue 49009, Kalamazoo / US | 06 /
Birgerson, Lars 54 Hillcrest Road 08836, Martinsville / US | 07 /
Cetera, Pasquale 5 Pine Place 08801, Annandale / US | [2006/09] | Representative(s) | Summers, Victoria Clare, et al ATTENTION: ADDRESS INACTIVE - USE ASS-NR - CDR / FR | [N/P] |
| Former [2009/08] | Summers, Victoria Clare, et al Pfizer Limited European Patent Department Ramsgate Road Sandwich, Kent CT13 9NJ / GB | ||
| Former [2006/09] | Duncan, Garreth Andrew, et al Pfizer Limited, European Pharma Patent Department, Ramsgate Road Sandwich Kent CT13 9NJ / GB | Application number, filing date | 05111705.9 | 22.06.2000 | [2006/09] | Priority number, date | US19990141968P | 01.07.1999 Original published format: US 141968 P | US19990144131P | 16.07.1999 Original published format: US 144131 P | US19990158256P | 06.10.1999 Original published format: US 158256 P | US19990170381P | 13.12.1999 Original published format: US 170381 P | [2006/09] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1629843 | Date: | 01.03.2006 | Language: | EN | [2006/09] | Type: | A3 Search report | No.: | EP1629843 | Date: | 15.03.2006 | [2006/11] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 27.01.2006 | Classification | IPC: | A61K31/5375, A61P43/00 | [2006/09] | CPC: |
A61K31/5375 (EP);
A61P13/00 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/06 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P29/00 (EP);
A61P43/00 (EP)
(-)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2006/09] | Extension states | AL | 15.09.2006 | LT | 15.09.2006 | LV | 15.09.2006 | MK | 15.09.2006 | RO | 15.09.2006 | SI | 15.09.2006 | Title | German: | Reboxetin zur Behandlung des chronischen Müdigkeitssyndroms | [2006/09] | English: | Reboxetine for treating chronic fatigue syndrome | [2006/09] | French: | Reboxétine pour traiter le syndrome de fatigue chronique | [2006/09] | Examination procedure | 15.09.2006 | Examination requested [2006/43] | 23.10.2006 | Despatch of a communication from the examining division (Time limit: M06) | 02.05.2007 | Reply to a communication from the examining division | 19.12.2007 | Despatch of a communication from the examining division (Time limit: M04) | 21.04.2008 | Reply to a communication from the examining division | 18.02.2009 | Communication of intention to grant the patent | 29.06.2009 | Application deemed to be withdrawn, date of legal effect [2010/02] | 20.08.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2010/02] | Parent application(s) Tooltip | EP00941659.5 / EP1196172 | Fees paid | Renewal fee | 05.04.2006 | Renewal fee patent year 03 | 05.04.2006 | Renewal fee patent year 04 | 05.04.2006 | Renewal fee patent year 05 | 05.04.2006 | Renewal fee patent year 06 | 30.06.2006 | Renewal fee patent year 07 | 08.06.2007 | Renewal fee patent year 08 | 18.03.2008 | Renewal fee patent year 09 | Penalty fee | Additional fee for renewal fee | 30.06.2009 | 10 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]GB2014981 (ERBA FARMITALIA) [Y] 1-5 * page 2, column L, line 37 * * page 9, column L, line 38 - line 40; claim - *; | [Y] - HEALY D ET AL, "THE CLINICAL PHARMACOLOGIC PROFILE OF REBOXTINE: DOES IT INVOLVE THE PUTATIVE NEUROBIOLOGICAL SUBSTRATES OF WELLBEING ?", JOURNAL OF AFFECTIVE DISORDERS, ELSEVIER BIOCHEMICAL PRESS, AMSTERDAM, NL, (199812), vol. 51, no. 3, ISSN 0165-0327, pages 313 - 322, XP001012063 [Y] 1-5 * the whole document * DOI: http://dx.doi.org/10.1016/S0165-0327(98)00227-4 | [Y] - ANONYMOUS, "REBOXETINE - ANOTHER NEW ANTIDEPRESSANT", DRUG AND THERAPEUTICS BULLETIN, CONSUMERS ASSOCIATION, LONDON, GB, (199811), vol. 36, no. 11, ISSN 0012-6543, pages 86 - 88, XP001011361 [Y] 1-5 * the whole document * | [Y] - BURROWS G D ET AL, "ANTIDEPRESSANT EFFICACY AND TOLERABILITY OF THE SELECTIVE NOREPINEPHRINE REUPTAKE INHIBITOR REBOXETINE: A REVIEW", JOURNAL OF CLINICAL PSYCHIATRY, XX, XX, (1998), vol. 59, no. SUPPL 14, ISSN 0160-6689, pages 4 - 7, XP000989995 [Y] 1-5 * the whole document * | [Y] - MUCCI M, "Reboxetine: a review of antidepressant tolerability", JOURNAL OF PSYCHOPHARMACOLOGY, OXFORD UNIVERSITY PRESS, GB, (1997), vol. 11, no. 4, SUPPL, ISSN 0269-8811, pages 533 - 537, XP002113306 [Y] 1-5 * the whole document * | [Y] - The Merck Manual 17th Edition, WHITEHOUSE STATION, N.J., MERCK & CO., (199904), XP002362998 [Y] 1-5 * page 2481 - page 2482 * |